Jaguar Health (NASDAQ:JAGX) Stock Price Crosses Below 200-Day Moving Average – Should You Sell?

Shares of Jaguar Health, Inc. (NASDAQ:JAGX) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.42 and traded as low as $0.85. Jaguar Health shares last traded at $0.85, with a volume of 358,850 shares.

Jaguar Health Price Performance

The company has a quick ratio of 1.36, a current ratio of 1.84 and a debt-to-equity ratio of 1.65. The stock’s 50 day moving average price is $1.00 and its 200-day moving average price is $1.40.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Jaguar Health stock. Virtu Financial LLC bought a new stake in shares of Jaguar Health, Inc. (NASDAQ:JAGX) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned 0.22% of Jaguar Health at the end of the most recent reporting period. 12.04% of the stock is currently owned by institutional investors.

Jaguar Health Company Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.